Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT01832727 · TERMINATED
Trial details
- NCT number
- NCT01832727
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-02
- Primary completion
- 2019-06-25
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.